 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- Linjeta (prandial insulin) / Ipsen, Humalog pen (insulin lispro) / Eli Lilly
Enrollment change, Trial withdrawal: A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars. (clinicaltrials.gov) - Feb 11, 2017
P2, N=0, Withdrawn, Sponsor: Stanford University
N=20 --> 0 | Suspended --> Withdrawn
- ||||| Linjeta (prandial insulin) / Ipsen
Enrollment change: An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject (clinicaltrials.gov) - Feb 3, 2013
P3, N=116, Completed, Sponsor: Biodel
N=20 --> 0 | Suspended --> Withdrawn N=286 --> 116